Shanghai Pharmaceuticals Holding Co.Ltd(601607) (SH Shanghai Pharmaceuticals Holding Co.Ltd(601607) , closing price: 24.42 yuan) announced on March 29 that Mr. Gu Haoliang, the former vice president of the company, will no longer serve as vice president of the company since March 30, 2022 due to his retirement; Ms. Chen Jinzhu, the former vice president, is still the Secretary of the board of directors of the company due to job transfer. The company agrees to appoint Mr. Zhong Tao, Mr. Li Dongming and Mr. Pan Deqing as vice presidents of the company until the expiration of the seventh board of directors.
From January to June 2021, Shanghai Pharmaceuticals Holding Co.Ltd(601607) the composition of operating revenue is: distribution accounts for 87.88%, industry accounts for 11.97%, retail accounts for 3.52%, others account for 0.22%, and internal offset accounts for – 3.93%.
the president of Shanghai Pharmaceuticals Holding Co.Ltd(601607) is Zuo min, male, 61 years old, with a master’s degree background.
